Fig. 7From: The new world of RNA diagnostics and therapeuticsGenome-wide approaches to study miRNA involved in DLBCL response to treatment. (A) Small-RNA sequencing on serum samples from DLBCL patients responding or refractory to R-CHOP treatment to identify miRNAs as predictive biomarkers. (B) CRISPR/Cas-9 library screening on a cell model of drug resistance to identity miRNAs as potential therapeutic targets (image created with BioRender.com)Back to article page